These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6494025)

  • 21. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.
    Antoni FA; Holmes MC; Makara GB; Kárteszi M; László FA
    Peptides; 1984; 5(3):519-22. PubMed ID: 6089144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of arginine vasopressin on acupuncture analgesia in the rat.
    Yang J; Yang Y; Wang CH; Wang G; Xu H; Liu WY; Lin BC
    Peptides; 2009 Feb; 30(2):241-7. PubMed ID: 19022309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of vasopressin analgesia.
    Berkowitz BA; Sherman S
    J Pharmacol Exp Ther; 1982 Feb; 220(2):329-34. PubMed ID: 7057394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic blood flow autoregulation remains unaltered following surgical and pharmacological blockade of central vasopressin.
    Sandor P; Petty M; de Jong W; Palkovits M; de Wied D
    Brain Res; 1991 Dec; 566(1-2):212-8. PubMed ID: 1814538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
    Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
    Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central effects of vasopressin and 1-desamino-8-D-arginine vasopressin (DDAVP) on interleukin-1 fever in the rat.
    Naylor AM; Gubitz GJ; Dinarello CA; Veale WL
    Brain Res; 1987 Jan; 401(1):173-7. PubMed ID: 2949799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors.
    Richardson SB; Laya T; VanOoy M
    J Endocrinol; 1995 Oct; 147(1):59-65. PubMed ID: 7490538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate social recognition in rat.
    Bluthé RM; Dantzer R
    Brain Res; 1992 Feb; 572(1-2):261-4. PubMed ID: 1611520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain vasopressin and sodium appetite.
    Flynn FW; Kirchner TR; Clinton ME
    Am J Physiol Regul Integr Comp Physiol; 2002 Apr; 282(4):R1236-44. PubMed ID: 11893630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of beta-endorphin on arginine-8-vasopressin and oxytocin levels in rat brain areas.
    Vecsernyés M; Laczi F; Kovács GL; Szabó G; Janáky T; Telegdy G; László FA
    Experientia; 1989 May; 45(5):472-4. PubMed ID: 2524402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin stimulates phosphatidylinositol turnover and aldosterone synthesis in rat adrenal glomerulosa cells: comparison with angiotensin II.
    Woodcock EA; Mcleod JK; Johnston CI
    Endocrinology; 1986 Jun; 118(6):2432-6. PubMed ID: 2938936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D; Elands J; Kovács G
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elimination of vasopressin analgesia following lesions placed in the rat hypothalamic paraventricular nucleus.
    Bodnar RJ; Truesdell LS; Haldar J; Aral IA; Kordower JH; Nilaver G
    Peptides; 1986; 7(1):111-7. PubMed ID: 3714529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraventricular administration of arginine vasopressin suppresses prolactin release via a dopaminergic mechanism.
    DePaolo LV; Berardo PV; Carrillo AJ
    Peptides; 1986; 7(3):541-4. PubMed ID: 3774591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebroventricular calcitonin gene-related peptide inhibits rat duodenal bicarbonate secretion by release of norepinephrine and vasopressin.
    Lenz HJ; Brown MR
    J Clin Invest; 1990 Jan; 85(1):25-32. PubMed ID: 2295700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.